Children With Asthma Have Impaired Innate Immunity and Increased Numbers of Type 2 Innate Lymphoid Cells Compared

Banafshe Hosseini1, Bronwyn S Berthon1, Malcolm R Starkey1,2,3

  • 1Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia.

Insights

Children with asthma exhibit impaired immune responses and reduced lung function. This study highlights altered immune cell subsets and cytokine production, crucial for understanding childhood asthma management.

Area of Science:

  • Pediatric immunology
  • Respiratory medicine
  • Cellular immunology

Background:

  • Childhood asthma is a leading cause of hospitalization.
  • Limited understanding of asthma's impact on pediatric immune responses.

Purpose of the Study:

  • Evaluate cytokine responses, immune cell composition, and lung function in children with and without asthma.
  • Investigate immune cell subsets and cytokine profiles in response to viral and bacterial stimuli.

Main Methods:

  • Case-control study comparing 48 children with asthma and 14 healthy controls.
  • Assessed peripheral blood mononuclear cells (PBMCs) cytokine production (IFN-γ, IL-1β, IL-5, IL-6) after stimulation with rhinovirus-1B (RV1B), house dust mite (HDM), and lipopolysaccharide (LPS).
  • Measured lung function using impulse oscillometry and nitrogen multiple breath washout.

Main Results:

  • Asthmatic children had higher group 2 innate lymphoid cells and deficient IFN-γ production to RV1B and LPS.
  • Elevated RV1B-induced IL-1β and HDM-stimulated IL-5 in asthmatics; reduced IL-1β and IL-6 with HDM/LPS stimulation.
  • Asthmatic children showed reduced pulmonary function, including lower respiratory reactance and higher lung clearance index.

Conclusions:

  • Childhood asthma is associated with impaired immune responses and altered immune cell subsets.
  • Findings suggest a link between reduced lung function and immune dysregulation in pediatric asthma.
  • Understanding these immune responses is key for tailoring childhood asthma management strategies.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.4K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
885
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.1K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.1K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K